WallStreetZenWallStreetZen

NASDAQ: ELOX
Eloxx Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ELOX

Based on 4 analysts offering 12 month price targets for Eloxx Pharmaceuticals Inc

Min Forecast
$32.00+139.88%
Avg Forecast
$38.25+186.73%
Max Forecast
$43.00+222.34%

Should I buy or sell ELOX stock?

Based on 5 analysts offering ratings for Eloxx Pharmaceuticals Inc.

Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ELOX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ELOX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their ELOX stock forecasts and price targets.

ELOX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-15
lockedlocked$00.00+00.00%2026-09-18
lockedlocked$00.00+00.00%2026-08-24
lockedlocked$00.00+00.00%2026-08-20
lockedlocked$00.00+00.00%2026-07-22

1 of 1

Forecast return on equity

Is ELOX forecast to generate an efficient return?

Company
-22.53%
Industry
-15.48%
Market
155.95%
ELOX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ELOX forecast to generate an efficient return on assets?

Company
-16.5%
Industry
-2.98%
ELOX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ELOX earnings per share forecast

What is ELOX's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$2.15
Avg 2 year Forecast
-$2.78
Avg 3 year Forecast
-$2.59

ELOX revenue forecast

What is ELOX's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

ELOX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ELOX$13.34$38.25+186.73%Strong Buy
YARW$20.12$58.00+188.27%Strong Buy
HYFT$1.16$5.00+331.03%Buy
INKT$10.63$42.50+299.81%Strong Buy
SDEV$1.05N/AN/A
View Top Biotech Stocks

Eloxx Pharmaceuticals Stock Forecast FAQ

Is Eloxx Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ELOX) stock is to Strong Buy ELOX stock.

Out of 5 analysts, 3 (60%) are recommending ELOX as a Strong Buy, 2 (40%) are recommending ELOX as a Buy, 0 (0%) are recommending ELOX as a Hold, 0 (0%) are recommending ELOX as a Sell, and 0 (0%) are recommending ELOX as a Strong Sell.

If you're new to stock investing, here's how to buy Eloxx Pharmaceuticals stock.

What is ELOX's earnings growth forecast for 2026-2028?

(NASDAQ: ELOX) Eloxx Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 66.43%.

Eloxx Pharmaceuticals's earnings in 2026 is N/A.On average, 5 Wall Street analysts forecast ELOX's earnings for 2026 to be -$8,659,819, with the lowest ELOX earnings forecast at -$11,273,830, and the highest ELOX earnings forecast at -$4,195,899. On average, 5 Wall Street analysts forecast ELOX's earnings for 2027 to be -$11,212,476, with the lowest ELOX earnings forecast at -$14,280,185, and the highest ELOX earnings forecast at -$7,756,056.

In 2028, ELOX is forecast to generate -$10,457,658 in earnings, with the lowest earnings forecast at -$12,183,648 and the highest earnings forecast at -$8,688,478.

What is ELOX's revenue growth forecast for 2026-2028?

(NASDAQ: ELOX) Eloxx Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 44.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.45%.

Eloxx Pharmaceuticals's revenue in 2026 is N/A.On average, 4 Wall Street analysts forecast ELOX's revenue for 2026 to be $0, with the lowest ELOX revenue forecast at $0, and the highest ELOX revenue forecast at $0. On average, 4 Wall Street analysts forecast ELOX's revenue for 2027 to be $0, with the lowest ELOX revenue forecast at $0, and the highest ELOX revenue forecast at $0.

In 2028, ELOX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is ELOX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ELOX) forecast ROA is -16.5%, which is lower than the forecast US Biotechnology industry average of -2.98%.

What is ELOX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ELOX price target, the average ELOX price target is $38.25, with the highest ELOX stock price forecast at $43.00 and the lowest ELOX stock price forecast at $32.00.

On average, Wall Street analysts predict that Eloxx Pharmaceuticals's share price could reach $38.25 by Oct 15, 2027. The average Eloxx Pharmaceuticals stock price prediction forecasts a potential upside of 186.73% from the current ELOX share price of $13.34.

What is ELOX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ELOX) Eloxx Pharmaceuticals's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that ELOX's EPS will be -$2.15 for 2026, with the lowest EPS forecast at -$2.79, and the highest EPS forecast at -$1.04. On average, analysts forecast that ELOX's EPS will be -$2.78 for 2027, with the lowest EPS forecast at -$3.54, and the highest EPS forecast at -$1.92. In 2028, ELOX's EPS is forecast to hit -$2.59 (min: -$3.02, max: -$2.15).

What is ELOX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ELOX) forecast ROE is -22.53%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.